{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:46:16Z","timestamp":1762505176923},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2006,10,1]]},"DOI":"10.2174\/138161206778559614","type":"journal-article","created":{"date-parts":[[2006,10,2]],"date-time":"2006-10-02T18:58:57Z","timestamp":1159815537000},"source":"Crossref","is-referenced-by-count":70,"title":["Sigma Receptor Ligands: Possible Application as Therapeutic Drugs and as Radiopharmaceuticals"],"prefix":"10.2174","volume":"12","author":[{"given":"Kiichi","family":"Ishiwata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/57978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T08:52:45Z","timestamp":1503651165000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/57978\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":0,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2006,10,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/138161206778559614","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10,1]]}}}